An interventional study of Demineralized Dentin Allograft and Demineralized Dentin Autograft in Alveolar Bone Loss, sponsored by Horus University. Recruiting at 1 site in Egypt. Open to participants aged 25 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-18.
Sponsored by Horus University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 75 studies in Alveolar Bone Loss with a site in Egypt — 22 open to participants now, 27 under way, none of them phase 3. Alveolar Bone Loss · Egypt.
Among the 75 studies in Alveolar Bone Loss with a site in Egypt, this one is the 8th largest by planned enrollment of the 74 interventional ones that give a count, is one of 9 that started in 2026, is one of 68 with no phase, reaches primary completion later than 26 of the 26 other live ones, and was the 38th registered.
320 studies on the registry are indexed under Alveolar Bone Loss; 79 are open to participants now.
Browse Alveolar Bone Loss studies →22 of the 75 studies in Alveolar Bone Loss with a site in Egypt are open now. Recruiting first, the newest first:
Beni-Suef University · Sites in Egypt
Ages 20–75 · Healthy volunteers
Al Salam University · Sites in Egypt
Ages 20–45 · Healthy volunteers
Future University in Egypt · Sites in Egypt
Ages 20–50
Basma Gamal Mohamed Ahmed · Sites in Egypt
British University In Egypt · Sites in Egypt
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 47 Alveolar Bone Loss studies recruiting now, 19 (40%) set no upper age limit and 22 (47%) stop at 75 or younger; 4 take children under 18; 24 take healthy volunteers.
This study: 25 Years to 35 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
75 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 2 · Phase 3 1 · Phase 4 2
First in 2018; this study’s year is marked. 9 started in 2026.
This study's planned enrollment of 40 is above the median of 25 across 271 interventional studies indexed under Alveolar Bone Loss.
Median enrollment 20 across the 74 interventional studies, 23 across the 1 observational. Of the 37 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 75 has an industry lead sponsor. The 10 most frequent:
Horus University is the lead sponsor of 33 studies on the registry; 11 are open to participants now.
Horus University has 1 study filed under Alveolar Bone Loss — fewer than ten, so there is no comparison to draw.
6 of the studies in Alveolar Bone Loss with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07475507Cairo UniversityEffect of PEEK and Titanium Framework Reinforcement on Marginal Bone Loss Around Implants Supporting a Fixed All-on-four Prosthesis in Completely Edentulous Mandibles | 2026-12 |
| NCT07701473Cairo UniversityNovel Synthetic Membrane for Horizontal Bone Augmentation: A Case Series | 2027-03-01 |
| NCT06313229Kafrelsheikh UniversitySimultaneous Implant Placement With Vertical and Horizontal Bone Augmentation | 2027-04-30 |
| NCT07841158Mohammed Mahmoud AbedHistological and Histomorphometric Assessment With Inflammatory Profile Analysis of Bone Tissue After Horizontal Ridge Augmentation Using Customized Porous Zirconia Shell | 2027-05-01 |
| NCT07869030Future University in EgyptMelatonin Effect on Immediate Dental Implants in the Posterior Mandible | 2027-06 |
Add all 6 to your calendar (.ics) → With an account.
Among the 75 studies in Alveolar Bone Loss with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is designed to evaluate and compare clinically and radiographically the effectiveness of Demineralized Dentin Allograft (DDA) versus Demineralized Dentin Autograft (Auto-DD) for preservation of alveolar ridge dimensions after surgical extraction of the impacted mandibular third molar.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
20 sockets will be grafted with Demineralized Dentin Allograft (DDA)
Procedure: Demineralized Dentin Allograft
20 sockets will be grafted with Demineralized Dentin Autograft (Auto-DD)
Procedure: Demineralized Dentin Autograft
20 sockets are randomly allocated to receive the Demineralized Dentin Allograft (split-mouth study)
Also known as: DDA
20 sockets are randomly allocated to receive the Demineralized Dentin Autograft (split-mouth study)
Also known as: Auto-DD
Measuring and comparing the height of bone between the two groups
We will measure the height of the alveolar ridge clinically by using ridge mapping caliper (special caliper forceps used for measuring ridge dimensions) and radiographically on the cone-beam computed tomography (CBCT) and comparing the results of the study group (20 sockets) with the control group (the other 20sockets), to assess the effectiveness of Demineralized Dentin Allograft for ridge preservation
Time frame: Immediately post-operative, 3months post-operative, 6months post-operative
Measuring and comparing the width of bone between the two groups
We will measure the width of the alveolar ridge clinically by using ridge mapping caliper (special caliper forceps used for measuring ridge dimensions) and radiographically on the cone-beam computed tomography (CBCT) and comparing the results of the study group (20 sockets) with the control group (the other 20sockets), to assess the effectiveness of Demineralized Dentin Allograft for ridge preservation
Time frame: Immediately post-operative, 3months post-operative, 6months post-operative
Assess and comparing the mouth opening of both groups
Assess the mouth opening of the patient using a millimeter ruler (by measuring the distance between maxillary incisal edge and mandibular incisal edge) and comparing the results of both groups
Time frame: One day post-operative, one week post-operative
Assess and comparing the swelling of both groups
Swelling levels after surgery will be measured using anatomic landmarks (Tragus-Labial commissure and Tragus-Pogonion), the distances between the landmarks used for the evaluation methods will be measured before the operation. All measurements will be done using millimeter ruler, while the patient will be seated.
Time frame: One day post-operative, one week post-operative
Assess and comparing the pain of both groups
we will use the Visual Analogue Scale (VAS) for pain measurement
Time frame: One day post-operative, one week post-operative
Assess and comparing the soft tissue parameters (bleeding on probing and color of the gingiva) of both groups
The bleeding on probing will be assessed by using periodontal probe and this will be done around mandibular first and second molars
Time frame: One day post-operative, one week post-operative
Plan to share: No
Started Aug 2026 (actual). Primary completion is estimated for Aug 2027, 11 months after the start.
Of 169 non-industry interventional studies with no phase under Alveolar Bone Loss, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's planned 11 months is below that.
Counting every sponsor, half of 169 studies reached it within 18 months; a quarter within 11 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Horus University